Study of Temsirolimus, Topotecan, and Bortezomib
NCT00770731
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
Torisel (Temsirolimus)
DRUG:
Hycamtin (Topotecan)
DRUG:
Velcade (Bortezomib)
Sponsor
M.D. Anderson Cancer Center